Weekly Digest – November 2024 Weekly Digest – November 2024 18 Nov 2024: VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate VelaVigo Cayman Limited has entered into an agreement with Avenzo Therapeutics, […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id